ANIX
Anixa Biosciences Inc

10,470
Mkt Cap
$136.28M
Volume
0.00
52W High
$4.98
52W Low
$2.07
PE Ratio
-12.01
ANIX Fundamentals
50D MA
$3.49
Beta
1.04
Avg. Volume
136,233.14
EPS (Annual)
-$0.3936
P/B
8.19
Rev/Employee
$0.00
Loading...
Loading...
Anixa Biosciences, Inc. is a biotechnology company, which engages in the development of therapies and vaccines focused on oncology and infectious disease. It operates through the following segments: Cancer Vaccines, CAR-T Therapeutics, and Other. The Cancer Vaccines segment includes the early stages development of immunization for breast and ovarian cancer. The CAR-T Therapeutics segment is involved in the development of immuno-therapy drugs against cancer. The company was founded on November 5, 1982 and is headquartered San Jose, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
5

Frequently Asked Questions

What is Market Cap of Anixa Biosciences Inc?
What is the 52-week high for Anixa Biosciences Inc?
What is the 52-week low for Anixa Biosciences Inc?
What is the PE ratio of Anixa Biosciences Inc?
What is the Price-to-Book ratio of Anixa Biosciences Inc?
What is the 50-day moving average of Anixa Biosciences Inc?
How many employess does Anixa Biosciences Inc has?

Latest ANIX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.